The Relative Contribution of Amyloid, Tau, Neurodegeneration, and Vascular Disease to Cognition and Cognitive Decline: A Cross‐National Study

Abstract

Background: Recent in vivo biomarker advancements have led to biological diagnostic and staging criteria for AD based on amyloid(“A”), tau(“T”), and neurodegeneration(“N”).

The paper